MEDP Medpace Holdings Inc

Price (delayed)

$162.43

Market cap

$5.8B

P/E Ratio

39.91

Dividend/share

N/A

EPS

$4.07

Enterprise value

$5.64B

Sector: Healthcare
Industry: Diagnostics & Research

Highlights

The EPS is up by 46% YoY and by 18% QoQ
The net income has increased by 45% YoY and by 17% from the previous quarter
The P/E is 31% higher than the last 4 quarters average of 30.5 but 20% lower than the 5-year quarterly average of 49.7
The debt has soared by 155% year-on-year and by 4% since the previous quarter

Key stats

What are the main financial stats of MEDP
Market
Shares outstanding
35.73M
Market cap
$5.8B
Enterprise value
$5.64B
Valuations
Price to earnings (P/E)
39.91
Price to book (P/B)
7.21
Price to sales (P/S)
6.25
EV/EBIT
33.54
EV/EBITDA
27.97
EV/Sales
6.09
Earnings
Revenue
$925.93M
EBIT
$168.23M
EBITDA
$201.68M
Free cash flow
$227.34M
Per share
EPS
$4.07
Free cash flow per share
$6.38
Book value per share
$22.53
Revenue per share
$25.98
TBVPS
$19.13
Balance sheet
Total assets
$1.39B
Total liabilities
$584.9M
Debt
$115.14M
Equity
$805.78M
Working capital
$33.54M
Liquidity
Debt to equity
0.14
Current ratio
1.08
Quick ratio
1
Net debt/EBITDA
-0.81
Margins
EBITDA margin
21.8%
Gross margin
30.1%
Net margin
15.7%
Operating margin
18%
Efficiency
Return on assets
11.5%
Return on equity
19%
Return on invested capital
207.4%
Return on capital employed
17.7%
Return on sales
18.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MEDP stock price

How has the Medpace Holdings stock price performed over time
Intraday
2.14%
1 week
1.9%
1 month
17.69%
1 year
61.65%
YTD
16.69%
QTD
16.69%

Financial performance

How have Medpace Holdings's revenue and profit performed over time
Revenue
$925.93M
Gross profit
$278.73M
Operating income
$167.04M
Net income
$145.38M
Gross margin
30.1%
Net margin
15.7%
The net income has increased by 45% YoY and by 17% from the previous quarter
The net margin is up by 34% year-on-year and by 13% since the previous quarter
The operating income has increased by 31% year-on-year and by 13% since the previous quarter
The operating margin has grown by 22% YoY and by 9% from the previous quarter

Growth

What is Medpace Holdings's growth rate over time

Valuation

What is Medpace Holdings stock price valuation
P/E
39.91
P/B
7.21
P/S
6.25
EV/EBIT
33.54
EV/EBITDA
27.97
EV/Sales
6.09
The EPS is up by 46% YoY and by 18% QoQ
The P/E is 31% higher than the last 4 quarters average of 30.5 but 20% lower than the 5-year quarterly average of 49.7
MEDP's price to book (P/B) is 112% higher than its 5-year quarterly average of 3.4 and 50% higher than its last 4 quarters average of 4.8
Medpace Holdings's equity has increased by 11% YoY
MEDP's price to sales (P/S) is 95% more than its 5-year quarterly average of 3.2 and 52% more than its last 4 quarters average of 4.1
MEDP's revenue is up by 8% year-on-year and by 3.3% since the previous quarter

Efficiency

How efficient is Medpace Holdings business performance
MEDP's ROIC has shrunk by 54% YoY and by 16% QoQ
The company's return on equity rose by 28% YoY and by 14% QoQ
The ROS is up by 24% YoY and by 9% QoQ
Medpace Holdings's return on assets has increased by 21% YoY and by 11% QoQ

Dividends

What is MEDP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MEDP.

Financial health

How did Medpace Holdings financials performed over time
The company's total assets is 138% higher than its total liabilities
The total liabilities has grown by 40% YoY and by 16% from the previous quarter
The company's total assets rose by 22% YoY and by 7% QoQ
The debt is 86% smaller than the equity
The debt has soared by 155% year-on-year and by 4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.